Medmira ( (TSE:MIR)) has shared an update. MedMira reported first-quarter fiscal 2026 results marked by Health Canada approval of its Reveal TP rapid syphilis antibody test, enabling nationwide ...
University of Alberta-led research reports that new cases of syphilis dropped in Alberta following the introduction of rapid point-of-care testing and same-day treatment. The research team compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results